Review decision: November 2015

We checked this guideline and decided that it should be updated at this time. For details, see the update decision, decision matrix and the process for deciding if an update is needed. Details of the update will be available on the guidelines in development webpage in due course. This guideline will be checked again for update at its scheduled time point according to the methods described here

Next review date: 2017

This clinical guideline updates and replaces NICE guideline CG14 and CG41 (published in October 2006).

It offers evidence-based advice on the classification and care of people at risk of familial breast cancer. It also makes recommendations on genetic testing thresholds, surveillance and risk reduction and treatment strategies for people with a diagnosis of breast cancer and a family history of breast, ovarian or a related cancer.

These areas are not covered by NICE guideline CG80 (Breast cancer: early and locally advanced, published in February 2009).

This guideline was previously called familial breast cancer: classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer (CG164).

  • National Institute for Health and Care Excellence (NICE) accreditation logo